Patents by Inventor Christopher Kilbane

Christopher Kilbane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10561792
    Abstract: The disclosure is directed to a drug delivery device comprising a housing retaining a primary drug delivery assembly and a secondary drug delivery assembly. The secondary drug delivery assembly comprises a secondary dose setting mechanism with a biasing member adapted to reset the secondary dose setting mechanism in a resetting movement. An actuator is movable relative to the housing and comprises a first engagement section configured to engage a second engagement section provided by an actuation collar such that an actuation movement of the actuator is transferred to the actuation collar. A setting element is movable between a first position and a second position and is connected to the secondary dose setting mechanism such that during the resetting movement of the secondary dose setting mechanism, the setting element is moved from the second position into the first position.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: February 18, 2020
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Marc Holtwick, Wolfgang Marx, Andreas Bode, James West, Paul Hayton, James Coop, Christopher Kilbane
  • Publication number: 20170165430
    Abstract: The invention is directed to a housing (7) for a drug delivery device comprising a first receiving section (14) for retaining a primary drug delivery assembly (16) and a second receiving section (15) for retaining a secondary drug delivery assembly (17). A movable actuator (34) comprises a first engagement section (55) and an actuation collar (37) comprises a second engagement section (53). A setting element (35) is movable around a second longitudinal axis (5) from a first position into a second position during a setting movement (56) and drives the actuation collar (37) into engagement with the actuator (34), wherein in the first position of the setting element (35) the actuator (34) is free to move relative to the actuation collar (37) and in the second position of the setting element (35) the actuation collar (37) engages the actuator (34) such that an actuation movement (63) of the actuator (34) is transferred to the actuation collar (37).
    Type: Application
    Filed: May 27, 2015
    Publication date: June 15, 2017
    Inventors: Marc Holtwick, Wolfgang Marx, Andreas Bode, James West, Paul Hayton, James Coop, Christopher Kilbane
  • Publication number: 20170151389
    Abstract: The invention is directed to a drug delivery device (1) comprising a housing (7) retaining a primary drug delivery assembly (16) and a secondary drug delivery assembly (17). The secondary drug delivery assembly (17) comprises a secondary dose setting mechanism with a biasing member adapted to reset the secondary dose setting mechanism in a resetting movement (65). An actuator (34) is movable relative to the housing (7) and comprises a first engagement section (55) configured to engage a second engagement section (53) provided by an actuation collar (37) such that an actuation movement (63) of the actuator (34) is transferred to the actuation collar (37).
    Type: Application
    Filed: May 27, 2015
    Publication date: June 1, 2017
    Inventors: Marc Holtwick, Wolfgang Marx, Andreas Bode, James West, Paul Hayton, James Coop, Christopher Kilbane
  • Patent number: D637859
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: May 17, 2011
    Assignee: Mars Drinks UK Limited
    Inventors: James Orkney, Christopher Kilbane
  • Patent number: D664258
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: July 24, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Thomas Harkin, Christopher Kilbane, Sebastian Liedtke